These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4976352)

  • 41. [Local chemotherapy of bladder epitheliomas].
    Martinez-Piñeiro JA
    Acta Oncol (Madr); 1970; 9(1):1-27. PubMed ID: 4990619
    [No Abstract]   [Full Text] [Related]  

  • 42. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide.
    Bruce D; Edgcomb JH
    J Urol; 1967 Mar; 97(3):482-5. PubMed ID: 4960046
    [No Abstract]   [Full Text] [Related]  

  • 44. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract]   [Full Text] [Related]  

  • 46. Recurrence prophylaxis of bladder cancer.
    Pavone-Macaluso M
    Ann Chir Gynaecol; 1984; 73(4):243. PubMed ID: 6508205
    [No Abstract]   [Full Text] [Related]  

  • 47. Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor.
    Hu KN; Kim A; Khan AS; Soroff H; Gonder M
    Cancer; 1985 Apr; 55(8):1654-8. PubMed ID: 3156664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New experience with cytostatics, especially their intra-arterial use in bladder tumors].
    Reuter JH
    Z Urol Nephrol; 1966 Feb; 59(2):125-8. PubMed ID: 4964957
    [No Abstract]   [Full Text] [Related]  

  • 49. Early multiple-dose adjuvant thiotepa in the control of multiple and rapid T1 tumour neogenesis.
    England HR; Flynn JT; Paris AM; Blandy JP
    Br J Urol; 1981 Dec; 53(6):588-92. PubMed ID: 6797501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors.
    Rodrigues Netto Júnior N; Lemos GC
    J Urol; 1983 Jan; 129(1):33-4. PubMed ID: 6402610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS; Slocum HK; Rustum YM; Greco WR; Gaeta JF; Huben RP
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC
    Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature.
    Silberberg JM; Zarrabi MH
    J Urol; 1987 Aug; 138(2):402-3. PubMed ID: 3110436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemotherapy of bladder neoplasms--studies of preventive measures against recurrence of superficial bladder neoplasms].
    Okajima E; Motomiya Y; Ishuin M; Ikuma S; Ohara S
    Nihon Rinsho; 1977 May; 35(5):1987-91. PubMed ID: 407385
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
    Melekos MD; Chionis HS; Paranychianakis GS; Dauaher HH
    Cancer; 1993 Sep; 72(5):1749-55. PubMed ID: 8348504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Local mitomycin-C therapy of infiltrating bladder cancer].
    Erdmann WD; Harzmann R; Flüchter SH; Bichler KH
    Fortschr Med; 1984 Aug; 102(29-30):767-71. PubMed ID: 6437950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.